Home » Newsletters » BioWorld Science

BioWorld Science

June 14, 2017

View Archived Issues

New S1P1-specific PET radioligands for imaging neuroinflammation show promise

Sunovion files IND for second compound from drug discovery collaboration with PsychoGenics

OSE Immunotherapeutics collaborates with Memorial Sloan Kettering on OSE-703

Carma Therapeutics closes initial financing

DSMB recommends continuation of NASH-CX trial of GR-MD-02

FDA awards fast track designation to tanezumab for chronic pain indications

AbbVie and Principia Biopharma establish oral immunoproteasome inhibitor collaboration

[18F]FC-0324, a new PET tracer targeting cannabinoid CB2 receptors

Zafgen details results from first-in-human trial of obesity candidate ZGN-1061

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents ALK inhibitors

Moleculin Biotech starts IND preparation for WP-1220 for CTCL

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

AbbVie discovers 5-HT2C receptor agonists

Pulmatrix in-licenses RespiVert kinase inhibitors

Ohara Pharmaceutical discloses prodrugs of azacytidine and decitabine

Genentech and Xenon Pharmaceuticals disclose Nav1.7 channel blockers

Grant supports BrainStorm Cell Therapeutics' development of NurOwn

Galapagos compound GLPG-1690 given U.S. orphan designation for idiopathic pulmonary fibrosis

NCI grant supports continued research at Case Western on Barrett's esophagus

[18F]GE-180 evaluated in patients with high grade glioma and multiple sclerosis

AbbVie drug receives FDA orphan status for onchocerciasis and lymphatic filariasis

IT-139 named a U.S. orphan drug for pancreatic cancer

FDA grants breakthrough therapy designation for OMS-721 in IgA nephropathy

Phase III trial of Bronchitol in cystic fibrosis meets primary endpoint

Cellth Systems granted rights to CTC cell-tethering technology

Repurposed cancer drug SU-9516 may have potential for Duchenne muscular dystrophy

FDA issues 510(k) clearance for Techlab's E. Histolytica Quik Chek test

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...